Morningstar

Bio-Techne Corp TECH

Morningstar Rating
Unlock
Stock XNAS Rating as of
$51.99 −1.19 (2.24%)
View Full Chart
As of Delayed Price Pre-Open: $52.25 +0.25

Company Report

View Archive

Price vs Fair Value

View History
TECH is trading at a 148% premium.
Price
$51.99
Fair Value
$21.00
Uncertainty
High
1-Star Price
$38.00
5-Star Price
$19.00
Economic Moat
Pmlmx
Capital Allocation
Rffvgfqxm

Bulls Say, Bears Say

Bulls

The firm's reputation for excellent proteomic reagents and instruments allows it to generate high profit margins and strong cash flow.

Bears

Bio-Techne's long-term strategy relies on acquisitions, and the company may have difficulty finding suitable targets because of high valuations or scarcity. Additionally, it may fail to successfully integrate and scale up an acquired business.

Show More

News

View All

Trading Information

Previous Close Price
$53.18
Day Range
$51.27–53.18
52-Week Range
$43.20–72.16
Bid/Ask
$51.10 / $52.90
Shares Outstanding
156.57M
Market Cap
$8.14B
Volume/Avg
418 / 3M

Key Statistics

Price/Earnings (Normalized)
26.79
Price/Sales
6.74
Dividend Yield (Trailing)
0.62%
Dividend Yield (Forward)
0.62%
Total Yield
1.85%

Company Profile

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
3,100
Website
https://www.bio-techne.com

Competitors

Valuation

View More
Metric
TECH
BIO
TMO
Price/Earnings (Normalized)
 26.7931.7520.41
Price/Book Value
 3.901.153.38
Price/Sales
 6.743.073.94
Price/Cash Flow
 25.6217.6818.27
Price/Earnings
TECH
BIO
TMO

Financial Strength

Metric
TECH
BIO
TMO
Quick Ratio
 2.772.170.97
Current Ratio
 4.493.211.53
Interest Coverage
 15.843.885.35
Quick Ratio
TECH
BIO
TMO

Profitability

Metric
TECH
BIO
TMO
Return on Assets (Normalized)
 11.85%2.51%8.27%
Return on Equity (Normalized)
 15.17%3.59%17.01%
Return on Invested Capital (Normalized)
 12.94%2.71%10.28%
Return on Assets
TECH
BIO
TMO

Biotechnology Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
CqvwyxkszHqyhyn$113B
 Regeneron Pharmaceuticals Inc
REGN
NwylmpxhFzmkw$67B
 argenx SE ADR
ARGX
WkrysjyGhjy$55B
 Alnylam Pharmaceuticals Inc
ALNY
TtnlqdqpGqkml$40B
 Royalty Pharma PLC Class A
RPRX
MwpcxsnkptCrdrrg$25B
 BioNTech SE ADR
BNTX
DwtnzqltsNvhc$22B
 Incyte Corp
INCY
GyhxynzyJwbc$20B
 Moderna Inc
MRNA
DhgmlwpgVhksp$19B
 Jazz Pharmaceuticals PLC
JAZZ
KcsczhsmJqhk$15B
 BridgeBio Pharma Inc
BBIO
YzsxsthhLdnb$13B

Sponsor Center